On 13 October 2026, on the occasion of the adoption of the Political Declaration on Pandemic Prevention, Preparedness, and ...

On 29 September 2026 in Washington, D.C., IFPMA delivered a statement on the strategy for strengthening health emergency and ...

In this op-ed, authors argue that Europe will be among the first to confront the central question of how to ensure that ...

On 1 October 2026 in Washington, D.C., IFPMA delivered a statement on the policy on the application of data science in public ...

This op-ed argues that Japan, as the world's first super-aging society, can set a global standard for how prevention protects ...

Governments around the world are confronting increasingly common challenges: how to drive economic growth, address demographic changes and productivity pressures, and how to strengthen national ...

In this op-ed, authors argue that Europe will be among the first to confront the central question of how to ensure that ...

Scientific progress can only realize its full potential when accompanied by public confidence in the institutions, expertise and evidence that underpins it. This close-door roundtable will bring ...

Pharmaceutical innovation – the core of our industry’s work – relies on pushing the limits of scientific knowledge to advance new medicines and vaccines for the benefit of people everywhere.

Anna Puchot supports strategic communications across IFPMA’s priority policy areas. Her work includes the development of policy communications, stakeholder engagement, member-facing content, and ...

17 October 2023, Geneva – A draft of the World Health Organization (WHO) Intergovernmental Negotiating Body’s (INB) international instrument on pandemic prevention, preparedness and response, commonly ...

Global health security has rarely been more important — nor more fragile. Rapid urbanization, demographics changes, climate-related events, displacement, and conflict are straining health systems and ...